Cartesian Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened
Cartesian Therapeutics, Inc. announced its financial results for the quarter ended June 30, 2026 in a press release dated August 6, 2026. The company furnished the full text of that press release as Exhibit 99.1 to its Current Report on Form 8-K (Item 2.02).

Key Details

• Filing date: August 6, 2026 (Form 8-K filed to disclose results of operations and financial condition).
• Reporting period: quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the 8-K.
• Interactive cover page data provided in Inline XBRL (Exhibit 104).

Why It Matters
This filing notifies investors that Cartesian has released its most recent quarterly financial results; investors should review the furnished press release for revenue, earnings, cash position, guidance, or other operational details. The Inline XBRL exhibit makes the company’s reported financial data easier to analyze and compare with peers and prior periods.